(176k) Closer to Reality: Development of Biocompatible Hydrogels to Validate Antitumor Activity and Specificity of a New Targeted paclitaxel Nanovehicle through 3D Cell Cultures
AIChE Annual Meeting
2019
2019 AIChE Annual Meeting
Food, Pharmaceutical & Bioengineering Division
Poster Session: Engineering Fundamentals in Life Science
Monday, November 11, 2019 - 3:30pm to 5:00pm
Thus, numerous research groups are now focusing on the development of 3D cancer cell cultures or tumor spheroids, grown in specialized gels or matrices, which better mimic natural tumor conditions [2]. Thereby, this is the main goal of the present work: fabricating a hydrogel using biocompatible materials such as silk fibroin and gellan gum, which allows to 3D-culture cells from the HER2-positive breast carcinoma cell line BT474 to validate the therapeutic action and specificity of a novel paclitaxel-trastuzumab combined nanovehicle synthetized in a previous work.
To achieve this objective, BT474 cells were cultured and introduced to form tumor spheroids, and their growth into the hydrogel was characterized. Consequently, they were treated with the aforementioned paclitaxel-trastuzumab combined nanovehicle. Obtained results have been compared to the already verified nanovehicleâs antitumor effect in conventional 2D cultures and, in this manner, the establishment of a more accurate in vitro validation method has been achieved.
References
[1] Alemany-Ribes M., Semino C.E. Adv. Drug Deliv. Rev., 2014, 79-80, 40-49.
[2] Gurski L.A., Jha A.K., Zhang C., Jia X, Farach-Carson M.C. Biomaterials, 2009, 30, 6076-6085.
[3] Román J.V., RodrÃguez-RodrÃguez J.A., MartÃn del Valle E.M., Galán M.A. Polym. Adv. Technol., 2016, 27, 623-629.